Ingrid Boere

Patient-derived organoids as predictor of clinical response in ovarian cancer: a systematic review

Patient-derived organoids (PDOs) have emerged as promising preclinical models for functional drug testing in ovarian cancer, with potential to support personalized treatment selection. However, their predictive value for clinical treatment response remains unclear. This systemati...